COVID-19 受试者的胰腺β细胞命运。
Pancreatic β-cell fate in subjects with COVID-19.
机构信息
Laboratory of Diabetes and Metabolic Disorders, Institute for Molecular and Cellular Regulation (IMCR), Gunma University, Maebashi, Japan.
出版信息
J Diabetes Investig. 2021 Dec;12(12):2126-2128. doi: 10.1111/jdi.13671. Epub 2021 Sep 27.
Abstract
Two recent reports denoted the potential of SARS-CoV-2 to directly infect β-cells and the possible fate of β-cells under COVID-19. The fight against SARS-CoV-2 will continue to develop more effective therapeutic strategies for diabetes.
摘要
最近有两项研究报告指出了 SARS-CoV-2 可能直接感染β细胞，以及 COVID-19 下β细胞可能的命运。抗击 SARS-CoV-2 将继续开发针对糖尿病更有效的治疗策略。
Zotero 插件